Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356090-26-000017
Filing Date
2026-05-13
Accepted
2026-05-13 16:20:32
Documents
87
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pgen-20260331.htm   iXBRL 10-Q 1018923
2 EX-31.1 pgen-20260331xexx311.htm EX-31.1 10210
3 EX-31.2 pgen-20260331xexx312.htm EX-31.2 9873
4 EX-32.1 pgen-20260331xexx321.htm EX-32.1 5711
5 EX-32.2 pgen-20260331xexx322.htm EX-32.2 5788
  Complete submission text file 0001356090-26-000017.txt   6719672

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pgen-20260331.xsd EX-101.SCH 51523
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pgen-20260331_cal.xml EX-101.CAL 80488
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pgen-20260331_def.xml EX-101.DEF 205456
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pgen-20260331_lab.xml EX-101.LAB 675749
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pgen-20260331_pre.xml EX-101.PRE 451156
91 EXTRACTED XBRL INSTANCE DOCUMENT pgen-20260331_htm.xml XML 842784
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36042 | Film No.: 26973647
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)